Introduction
The term 'prostatitis' is used to describe several conditions, including well-defined acute and chronic bacterial infections, poorly defined chronic pelvic pain syndrome and asymptomatic inflammation in the prostate, identified in pathology specimens. To limit the confusion, the National Institutes of Health (NIH) developed a classification system and definitions for the prostatitis syndromes 1 (Table 1) .
Although literature reviews provide compelling evidence that histological prostatitis is common 2,3 and symptomatic, clinically evident prostatitis is of greater importance to the patient and the physician. The prevalence of current prostatitis-like symptoms 4, 5 or an earlier physician's diagnosis of prostatitis 6 is about 10%.
This study focuses on the predominant type of prostatitis, NIH Category III or chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS). CP/CPPS is a common, 7 bothersome condition among men of all ages that impairs health-related quality of life 8, 9 and has a substantial economic impact. 10, 11 The hallmark of CP/CPPS is the pain in pelvic area. 12 The NIH Chronic Prostatitis Symptom Index (Figure 1 ) is a reliable, valid, self-administered index that measures symptoms of chronic prostatitis and their impact on daily life. 13 Although patients with CP/CPPS have traditionally been managed by urologists, many present first to primary care physicians (PCPs) with symptoms suggestive of CP/CPPS. Nonetheless, few studies [14] [15] [16] have examined what is known about PCPs' practice patterns regarding CP/CPPS. To ascertain the knowledge, attitudes and beliefs of PCPs regarding the diagnosis and treatment of CP/CPPS, we conducted a multi-center survey of PCPs in 2006.
Methods

Study sample
There was a convenience sample of 556 practicing PCPs, who were eligible for the study at the participating institutions (Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), University of California Los Angeles (UCLA) and Access Community Health Network (Access)). Access, located in Chicago, is the largest federally qualified health center organization in the United States. Lists of affiliated PCPs were obtained from the participating institutions, and these lists were refined using information provided by the General Medicine Divisions and the hospital directories to exclude physicians without direct patient care, residents and fellows, and those seeing only pediatric patients. A current interoffice mailing address was obtained for each physician.
Study design
The Institutional Review Board of each institution approved the study and survey. Brief (o15 min), selfadministered, pre-tested questionnaires were mailed to 556 physicians at the three institutions. The mailing included a cover letter from the Principal Investigator, a Primary care physician and prostatitis EA Calhoun et al fact sheet describing the study, a $5 coffee gift card, and a pre-stamped, pre-addressed return envelope. About 2 weeks after the initial mailing, all physicians were mailed a brief one-page thank you/reminder letter. Non-respondents were sent a second complete packet about 3 weeks after the initial mailing. No further attempts to contact non-respondents were made. Voluntary completion and return of the survey implied informed consent.
Questionnaire development
A literature review identified three survey studies of PCPs regarding CP/CPPS as a starting point in questionnaire development. [14] [15] [16] Across the study sites of Boston, Chicago and Los Angeles, we conducted a series of five PCP focus groups and subsequently drafted a preliminary questionnaire. The draft questionnaire was modified after several cognitive interviews with PCPs across the three study sites. The modified questionnaire was then pre-tested (with PCPs as well as a panel of five experts in CP/CPPS from North America) and refined after the debriefing. The finalized questionnaire included five domains: familiarity and experience with CP/CPPS, diagnosis (which included referral threshold), treatment, perceptions on managing patients with CP/CPPS (which included knowledge questions) and demographics. A vignette was presented and used to 'anchor' responses to questions regarding how the physicians would evaluate and treat such a patient. The vignette read as follows:
A healthy 38-year old man reports several months of nonspecific perineal pain and urinary frequency. He is in a longstanding, monogamous relationship and has no history of STDs or UTIs. His prostate examination is normal. His urinalysis is normal and his urine culture is negative.
For analytic purposes, diagnostic tests and treatment recommendations were stratified into common (at least 50% of respondents do it 'more than half the time' or 'almost always') and uncommon (at least 50% obtain a test 'rarely' or 'never', and recommend treatment to 'very few' or 'none').
Statistical analyses
This was a descriptive, cross-sectional study, which used questionnaires to obtain pertinent data. The completed questionnaires were keyed into a data entry system, and double blind data entry provided 100% verification of coding and data entry. Analyses primarily involved the generation of descriptive statistics with appropriate confidence intervals. All analyses were carried out at the data center (at the University of Illinois, Chicago, IL, USA) and used Statistical Package for the Social Sciences version 15. 17 Sample size. As part of the questionnaire development process, a set of correct answers was identified related to basic knowledge regarding CP/CPPS, and the proportion of PCPs who provided correct responses was calculated for each question. A similar study evaluating the practice patterns in PCPs for the diagnosis and treatment of BPH indicated that approximately one-third of these physicians followed all of the recommended guidelines. 18 As CP/CPPS is less familiar to PCPs than BPH, we expected that a lower proportion (estimated at 25%) would show an adequate knowledge. Assuming a 25% population prevalence of PCP correct responses and a 95% probability that the proportion obtained would be þ /À 5% of the population value, the sample size required was calculated to be approximately 288 participants.
Descriptives and predictors of PCPs' responses. Descriptive statistics were used for all survey responses and physician characteristics. w 2 -analyses and ANOVA (analysis of variance) were carried out to detect variation in having familiarity with the CP/CPPS condition, its symptoms and etiology, on the basis of the physician demographic characteristics. The ability to identify symptoms of CP/CPPS and its etiology were considered as knowledge questions, and responses were coded as correct and incorrect. Logistic regression analysis was used to predict which characteristics of PCPs were associated with the likelihood of carrying out various tests and recommending various treatments.
Results
Sample characteristics
Among the 556 PCPs who were mailed the questionnaire, a total of 289 (52%) responded, most of those (59%) from the initial mailing. The respondents were distributed approximately equally by gender (53% male), and the mean time since graduation from medical school was an average of 19 years (range 1-51). Respondent practice type was community-based (38%), hospital-based (40%) and private practice-based (22%) ( Table 2 ). 
Diagnosis of CP/CPPS
Only 62% (180/289) of respondents reported ever seeing a patient like the one described in the vignette. They had seen a mean of 3.2 patients like this (range 0-50) over the past 12 months, and reported a mean of 3.4 patients in their practice with a CP/CPPS diagnosis (0-30). Responders were asked, 'When evaluating a patient like the one in the vignette to confirm the diagnosis, or to rule out other causes of his symptoms, how often do you do the followingy'; their responses to the nine items are shown in Table 3 . We found that testing for Chlamydia and gonorrhea, and ordering serum creatinine were common diagnostic tests (reported being used at least more than half the time in 86 and 59%, respectively), and that obtaining pre-and post-massage urine cultures, ordering abdominal/pelvic CT scans, postvoid residuals and prostate ultrasounds were all uncommon diagnostic tests (range of 61-70%, used rarely or never). Although testing for prostate-specific antigen has not been shown to be helpful in the diagnosis of CP/CPPS, 19, 20 approximately 50% of respondents reported ordering this test about half the time or more.
Treatment of CP/CPPS
Physicians were asked, 'For how many of your patients like the one described in the vignette have you recommended treatment (either initial treatment or follow-up treatment) withy'; their response to the following 12 items are shown in Table 4 . Antibiotics were a common treatment recommendation (72% recommending more than half the time or almost always), whereas prostate massage, pelvic floor physical therapy, 5-alpha reductase inhibitors, bladder analgesics, complementary/alternative therapies, narcotic pain medications, anticonvulsants, antidepressants and anticholinergics were all uncommon recommendations (range of 75-97%, treated very few or none). Despite being a common treatment recommendation, the use of antibiotics for the treatment of men with CP/CPPS is not supported by the evidence. 21 Although the evidence for the use of alpha blockers is inconsistent, 22 we found that 41% of respondents recommended this treatment about half the time or more. Although not supported by the evidence, non-steroidal anti-inflammatory drugs are often considered an adjunctive medication and our results showed that 61% recommended anti-inflammatory medications about half the time or more.
Knowledge and perception of managing patients with CP/ CPPS
In all, 16% (46/289) were 'not at all' familiar with CP/ CPPS and 48% (139/289) were 'not at all' familiar with the NIH classification of prostatitis 1 ( Table 5 ). A total of 65% of respondents (188/289) correctly identified the hallmark symptom of CP/CPPS as pelvic pain. Regarding etiology, 71% (205/289) correctly indicated that the majority of cases of CP/CPPS were non-infectious; however, 37% (107/289) incorrectly indicated that it was caused by a sexually transmitted disease and 36% (104/289) incorrectly indicated that it was caused by a psychiatric illness. (Table 5 ).
We also asked how frequently the PCPs manage patients with other chronic conditions that often have 
Predictors of PCPs' responses
Using univariate analyses, we show that there are certain physician characteristics that are significantly associated with the likelihood of (1) having familiarity with CP/ CPPS in men (practice setting, male gender, more years of practice and higher percentage of male patients); (2) having knowledge of the hallmark symptoms of CP/ CPPS (male gender); and (3) having knowledge in managing patients with CP/CPPS (male gender, more years of practice, higher percentage of male patients). Table 7 presents only significant associations between physician characteristics, and familiarity and knowledge questions. In the multivariate analyses of PCPs' characteristics, and the likelihood of carrying out various tests and recommending various treatments, the results of the logistic regression analysis did not predict any consistent pattern in reporting various tests and recommending various treatments.
Discussion
Knowledge of physician practices, including approaches to diagnosis, treatment and management of patients is fundamental to both the development and evaluation of continuing medical education, medical school curricula and national educational programs. The emerging recognition of CP/CPPS as an important medical condition was the impetus for us to survey the diagnostic, treatment and management patterns of PCPs in the United States. 
5-Alpha reductase inhibitors
Almost all 0.60% More than half 0.60% Our study showed that many PCPs reported little or no familiarity with CP/CPPS, have important knowledge deficits and have limited experience in managing men with this syndrome. Over one-third of PCPs reported never having seen a patient like the one with CP/CPPS described in the vignette. PCPs reported practice patterns regarding diagnosis and treatment of CP/CPPS, which are not supported by evidence, such as ordering prostate-specific antigen tests and prescribing antibiotics. To effectively diagnose and treat CP/CPPS, physicians need to understand the NIH classification system for prostatitis; however, PCPs reported little or no familiarity with this classification scheme.
Two earlier survey studies carried out 10 and 15 years ago, respectively, were from Canada 16 and the Netherlands. The only study carried out in the United States, carried out 10 years ago, was from one county in the state of WI. 15 Earlier studies did not specifically ask PCPs regarding CP/CPPS, but instead referred to 'prostatitis' in general. We were particularly interested in surveying physicians regarding new cases of CP/ CPPS, as this is an important current research area. It is unclear whether the management of men with newly diagnosed CP/CPPS should vary from men with longstanding, treatment-refractory CP/CPPS. Unlike the earlier studies, we used a clinical vignette to be certain that PCPs were aware that our questions pertained to men with a specific type of prostatitis, namely CP/CPPS.
Although studies suggest that the symptoms of CP/ CPPS are common in the community 11, 23 and that 1% of all visits to PCPs are for the diagnosis 'prostatitis', 24 our data indicated that, in all, 38% (110/289) of PCPs reported never having seen a patient like the one with CP/CPPS described in the vignette. In addition, 16% (46/289) reported being 'not at all' familiar with the condition, CP/CPPS. Furthermore, PCPs in our study reported infrequently managing men with CP/CPPS; they reported more frequently managing other chronic pain conditions, such as chronic headache, chronic fatigue syndrome, irritable bowel syndrome and interstitial cystitis, which do not seem to have correspondingly higher population-based prevalence than CP/ CPPS. Whether these findings represent a large pool of men with CP/CPPS who do not seek care or seek care directly from urologists, or whether men who visit PCPs may not volunteer their CP/CPPS symptoms, or PCPs may not feel comfortable discussing them, cannot be determined from our survey. It is also possible that CPPS is less common than we think, as most visits for 'prostatitis' identified in studies such as the National Ambulatory Medical Care Survey studies 24 may not reflect CP/CPPS. Lastly, it could be that our sample of PCPs for this study may not be truly representative of PCPs in the community. Responding physicians also reported varying practice patterns regarding diagnosis, referral and treatment, and reported important knowledge deficits. Approximately half of the physicians in our survey study were 'not at all' familiar with the classification of prostatitis, which is a fundamental tenet to caring for men with CP/CPPS, and should be a key feature of any educational outreach efforts to PCPs. Our finding that almost one-third of PCPs did not correctly respond that the etiology of CP/CPPS is non-infectious, coupled with the finding that antibiotics were (inappropriately) the most common prescribed therapy, also suggest an essential need to educate PCPs. Acute and chronic bacterial prostatitis, which are infectious diseases, need to be differentiated from CP/ CPPS, which likely does not have an infectious etiology. In addition, approximately one-third of PCPs incorrectly reported that CP/CPPS is caused by psychiatric illness. Improved education of PCPs regarding CP/CPPS may help change this potentially damaging perception that the chronic pelvic pain in men is psychogenic. Finally, there is a potential for harm (that is, unnecessary anxiety, prostate biopsies) to men with symptoms suggestive of CP/CPPS by the inappropriate ordering of PSA tests, which our study showed was a common practice, yet there is no evidence to support this practice. 19, 20 Understandably, a big challenge in managing men with CP/CPPS remains the fact that there is neither a gold standard diagnostic test nor proven effective treatment; 25 therefore, there lacks an evidence-based clinical guideline to help PCPs in the management of this condition. Research is underway through the National Institutes of Diabetes and Digestive and Kidney Diseases-supported Multidisciplinary Approach to the Study of Chronic Pelvic Pain (www.Mappnetwork.org) to elucidate the natural history, etiology, and pathophysiology of this condition, such that early identification and intervention in primary care may result in improved outcomes for patients.
Another reason for educating primary care physicians regarding CP/CPPS is that this condition is among those that cause chronic non-malignant pain, an important new topic in primary care medicine. 26 As most PCPs are not comfortable treating patients with chronic non-malignant pain, educational efforts are underway to increase PCPs' willingness to manage patients with chronic pain. Educational efforts regarding CPPS in men could serve as a useful model of a chronic non-malignant pain condition during medical training, including medical school, residency, fellowship and continuing medical education courses.
Our study has several limitations. First, although our response rate of 52% is typical of physician surveys, 27 response bias is a possibility. Second, our study population was chosen by convenience sampling, therefore, our findings warrant replication in a larger, more representative sample. Third, the data on the practice patterns of PCPs were based on physician self-report and may not match the actual practice. Fourth, the associations between the physician characteristics and management practices must be viewed with caution, given that multiple tests of association were carried out.
In conclusion, the results of this multi-center, PCP survey study suggest that educational efforts on the care of patients with CP/CPPS should target PCPs, especially as pain is now considered the hallmark symptom of this syndrome and diagnosis, treatment and management of chronic non-malignant pain in primary care practice has become a national health care priority. Primary care physician and prostatitis EA Calhoun et al
